Management of DLBCL (Diffuse Large B-Cell Lymphoma): A Monocentric Experience

被引：0
作者：
Tlohi, Kawtar [1 ]
Benmoussa, Amine [1 ]
Harrach, Asmaa [1 ]
Lamchahab, Mouna [1 ]
Rachid, Mohamed [1 ]
Khoubila, Nissrine [1 ]
Cherkaoui, Siham [1 ]
Qachouh, Meryem [1 ]
Mandani, Abdellah [1 ]
机构：
[1] HASSAN II Univ, CHU IBN ROCH, Fac Med & Pharm, Dept Clin Hematol & Pediat Oncol, Casablanca, Morocco
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
ABCL; lymphoma; DLBCL; management; epidemiology; therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-411
引用
收藏
页码：S431 / S431
页数：1
相关论文
共 50 条
[31]   Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma [J].
Pirosa, Maria Cristina ;
Stathis, Anastasios ;
Zucca, Emanuele .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
[32]   Diffuse large B-cell lymphoma research in Malaysia: A review [J].
Lim, Kean Ghee ;
Sumera, Afshan ;
Burud, Ismail Abdul Sattar ;
Venkateswaran, Sunil Pazhayanur .
MALAYSIAN JOURNAL OF PATHOLOGY, 2023, 45 (01) :1-10
[33]   Late relapse in patients with diffuse large B-cell lymphoma [J].
Vose, Julie M. ;
Weisenburger, Dennis D. ;
Loberiza, Fausto R. ;
Arevalo, Alejandro ;
Bast, Martin ;
Armitage, Joel ;
Bierman, Philip J. ;
Bociek, Robert G. ;
Armitage, James O. .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) :354-358
[34]   A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) [J].
Flinn, Ian W. ;
Bartlett, Nancy L. ;
Blum, Kristie A. ;
Ardeshna, Kirit M. ;
LaCasce, Ann S. ;
Flowers, Christopher R. ;
Shustov, Andrei R. ;
Thress, Kenneth S. ;
Mitchell, Patrick ;
Zheng, Fred ;
Skolnik, Jeffrey M. ;
Friedberg, Jonathan W. .
EUROPEAN JOURNAL OF CANCER, 2016, 54 :11-17
[35]   A Potential Role of Ibrutinib in Stage IV Highly Aggressive Activated B Cell Type Diffuse Large B-Cell Lymphoma (ABC DLBCL) [J].
Mistry, Hemanshi ;
Hanova, Katerina ;
Natarajan, Piruthiviraj ;
Prieto, Roberto .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S419-S419
[36]   Diffuse large B-cell lymphoma: experience from a tertiary care center in north India [J].
Khera, Rohan ;
Jain, Snigdha ;
Kumar, Lalit ;
Thulkar, S. ;
Vijayraghwan, M. ;
Dawar, R. .
MEDICAL ONCOLOGY, 2010, 27 (02) :310-318
[37]   SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients [J].
Schif, Birgit ;
Lennerz, Jochen K. ;
Kohler, Christian W. ;
Bentink, Stefan ;
Kreuz, Markus ;
Melzner, Ingo ;
Ritz, Olga ;
Truemper, Lorenz ;
Loeffler, Markus ;
Spang, Rainer ;
Moeller, Peter .
ONCOTARGET, 2013, 4 (01) :35-47
[38]   Does Limited-Stage Diffuse Large B-Cell Lymphoma (LS-DLBCL) Matter? [J].
Martynchyk, Arina ;
Hawkes, Eliza A. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S44-S46
[39]   Detection of Double Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) A Single Center Study [J].
Alagizy, Hagar ;
Gohar, Suzy ;
Shams, Asmaa ;
Alaa, Mohammed .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 :S243-S244
[40]   Vitreoretinal Lymphoma as the Initial Presentation of a Breast Diffuse Large B-cell Lymphoma [J].
Martin, Cole A. ;
Admirand, Joan H. ;
Ghafoori, Shelley Day .
JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (05) :414-418
12345